Search for
Aldosterone Urine 24H
Reproductive
Report in 48Hrs
At Home
No Fasting Required
Details
24h urinary excretion of aldosterone.
₹2,738₹3,911
30% OFF
Aldosterone Urine 24H - Comprehensive Medical Test Guide
- Why is it done?
- Test Purpose: Measures the amount of aldosterone excreted in urine over a 24-hour period to evaluate adrenal gland function and assess electrolyte balance regulation
- Primary Indications: Diagnosis of primary hyperaldosteronism (Conn's syndrome), secondary hyperaldosteronism, hypertension evaluation, unexplained hypokalemia, adrenal insufficiency assessment
- Clinical Circumstances: Persistent hypertension unresponsive to standard treatment, resistant hypertension, electrolyte abnormalities with normal kidney function, evaluation of adrenal disorders, monitoring adrenal response to therapy
- Typical Timing: Performed during initial hypertension workup, after failed antihypertensive therapy, when aldosterone-renin imbalance is suspected, and during monitoring of adrenal replacement therapy
- Normal Range
- Reference Values: 2-26 µg/24 hours (typical adult reference range); may vary by laboratory methodology
- Units of Measurement: Micrograms per 24 hours (µg/24H) or nanomoles per 24 hours (nmol/24H depending on laboratory standards)
- Normal Results: Results within normal range indicate appropriate adrenal function and normal regulation of electrolyte balance; normal aldosterone suppression with sodium loading
- Elevated Results: Values >26 µg/24H suggest hyperaldosteronism; may indicate primary adrenal pathology or secondary response to volume depletion or renin-angiotensin system activation
- Decreased Results: Values <2 µg/24H may indicate adrenal insufficiency, renin-angiotensin system suppression, or excessive mineralocorticoid intake
- Borderline Values: Results at upper limits of normal may require additional testing such as plasma renin activity, sodium loading tests, or repeat measurement under standardized conditions
- Interpretation
- Markedly Elevated Aldosterone (>50 µg/24H): Strongly suggestive of primary hyperaldosteronism; warrants imaging of adrenal glands (CT/MRI) and plasma renin activity measurement to confirm diagnosis and identify aldosterone-producing adenoma or bilateral hyperplasia
- Mildly to Moderately Elevated (26-50 µg/24H): May indicate secondary hyperaldosteronism from volume depletion, renal disease, heart failure, cirrhosis, or primary hyperaldosteronism; requires correlation with clinical context and plasma renin-aldosterone ratio interpretation
- Low Aldosterone with Elevated Renin: Indicates adrenal insufficiency; suggests inability of adrenal cortex to respond appropriately to renin-angiotensin stimulation; requires further evaluation with ACTH stimulation testing
- Low Aldosterone with Suppressed Renin: May indicate excessive mineralocorticoid intake (licorice, fludrocortisone), primary hyperaldosteronism with suppressed renin, or volume expansion states
- Factors Affecting Results: Sodium intake (high sodium suppresses aldosterone), posture changes, medications (ACE inhibitors, ARBs, potassium-sparing diuretics, NSAIDs, beta-blockers), stress, time of collection, diurnal variation, pregnancy, menstrual cycle phase
- Clinical Significance: 24-hour urine aldosterone provides integration of secretion over extended period, reducing influence of diurnal variation; useful for screening before more invasive confirmatory tests; guides treatment decisions and differentiates primary from secondary causes of hyperaldosteronism
- Diagnostic Patterns: High aldosterone with suppressed plasma renin activity highly specific for primary hyperaldosteronism; helps differentiate from secondary causes where renin-aldosterone relationship is preserved or elevated renin drives aldosterone secretion
- Associated Organs
- Primary Organ System: Adrenal glands (zona glomerulosa), kidneys (renal tubular function and electrolyte reabsorption), renin-angiotensin-aldosterone system (RAAS)
- Conditions Associated with Elevated Results: Primary hyperaldosteronism (aldosterone-producing adenoma, bilateral adrenal hyperplasia), secondary hyperaldosteronism (renal disease, heart failure, cirrhosis, nephrotic syndrome), malignant hypertension, renal artery stenosis, volume depletion
- Conditions Associated with Decreased Results: Adrenal insufficiency (Addison's disease), adrenal atrophy, autoimmune adrenalitis, tuberculosis of adrenal glands, adrenal hemorrhage, adrenoleukodystrophy, congenital adrenal hyperplasia, surgical adrenalectomy
- Diseases Diagnosed or Monitored: Conn's syndrome (primary hyperaldosteronism), resistant hypertension, hereditary hyperaldosteronism, familial hyperaldosteronism type 1-3, Bartter syndrome, Gitelman syndrome
- Potential Complications of Abnormal Results: Hypokalemia with cardiac arrhythmias, metabolic alkalosis, left ventricular hypertrophy, increased cardiovascular morbidity and mortality, impaired glucose tolerance, hypomagnesemia, myopathy, accelerated renal disease progression if untreated
- Associated Renal Complications: Excessive sodium and fluid retention, potassium wasting, volume expansion leading to hypertension, glomerulosclerosis, chronic kidney disease progression, proteinuria
- Follow-up Tests
- Confirmatory Tests for Hyperaldosteronism: Plasma aldosterone concentration, plasma renin activity, aldosterone-to-renin ratio (ARR), saline suppression test, captopril challenge test, fludrocortisone suppression test
- Imaging Studies: Adrenal CT scan or MRI to identify adenoma or hyperplasia, adrenal vein sampling for lateralization studies, renal artery ultrasound or angiography if secondary hyperaldosteronism suspected
- Electrolyte Panel: Serum potassium, sodium, chloride, bicarbonate, pH to assess electrolyte abnormalities and acid-base status; monitor for hypokalemia and metabolic alkalosis
- Renal Function Tests: Serum creatinine, blood urea nitrogen (BUN), glomerular filtration rate (GFR), 24-hour urine creatinine for baseline renal function and monitoring disease progression
- Adrenal Insufficiency Confirmation: ACTH stimulation test (short and long forms), baseline cortisol, 17-hydroxyprogesterone, adrenal autoantibodies if autoimmune adrenalitis suspected
- Blood Pressure Monitoring: Home blood pressure monitoring, 24-hour ambulatory blood pressure monitoring (ABPM) to assess hypertension severity and response to treatment
- Cardiac Evaluation: Electrocardiogram (ECG) to assess for left ventricular hypertrophy and arrhythmia risk from hypokalemia, echocardiography if cardiac involvement suspected
- Monitoring Frequency: Baseline assessment initially, then every 6-12 months if under treatment; may repeat 24-hour urine aldosterone to assess response to therapy (spironolactone, amiloride, surgery)
- Related Complementary Tests: 24-hour urine sodium (to correlate with aldosterone suppression), urine potassium (to assess electrolyte wasting), urine osmolality, plasma osmolality for comprehensive endocrine assessment
- Fasting Required?
- Fasting Status: NO - Fasting is not required for 24-hour urine aldosterone collection
- Medication Instructions: Discontinue (2-4 weeks prior if possible): ACE inhibitors, angiotensin receptor blockers (ARBs), potassium-sparing diuretics (spironolactone, amiloride), loop diuretics, beta-blockers, NSAIDs, licorice-containing products, decongestants containing pseudoephedrine
- Dietary Requirements: Maintain normal sodium intake (not sodium-restricted), avoid excessive sodium loading, normal fluid intake, no dietary modifications needed
- Activity and Lifestyle: Maintain normal daily activities and posture, avoid prolonged bed rest or excessive recumbency which can lower aldosterone, continue normal sleep-wake cycle, avoid stress where possible as stress affects hormone levels
- Collection Instructions: Begin collection at 8 AM by discarding first morning void; collect all urine for exactly 24 hours until 8 AM next morning; record total urine volume; may require preservative in container (confirm with laboratory); refrigerate collection container during collection period
- Test Timing: Perform when patient has been off interfering medications for 2-4 weeks if clinically feasible; optimal collection when patient maintained on normal sodium diet (typically 100-150 mEq/day)
- Sample Handling: Transport to laboratory promptly after collection, maintain refrigeration during transport, inform laboratory of any medications patient is taking, document collection dates/times accurately
- Special Considerations: Pregnancy may elevate aldosterone; recent illness or hospitalization can affect results; inform physician of any acute illnesses; caffeine intake may minimally affect results but not typically a contraindication
How our test process works!
